Article of the month

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)

The data suggest that cancer patients have an increased risk of SARS-CoV-2 infections than non-cancer patients. However, prostate cancer patients receiving ADT appear to be partially protected from SARS-CoV-2 infections.

ESOU Online programme

Lecture Medical Oncology – What’s coming up in hormone-sensitive mPCa (hsmPCa)

Watch now

State of the Art – Uncertainties in treatment of localised Prostate Cancer

Watch now

EAU Guidelines on Prostate Cancer

Articles

Indirect comparisons of efficacy between combination approaches in metastatic hormone-sensitive prostate cancer: a systematic review and network meta-analysis

EAU Edu Platform on Prostate Cancer

Article of the month

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)

Upcoming events

Lisbon Masterclass on Prostate Cancer – LisPro

35th Annual EAU Congress (EAU20)

EAU Update on Prostate Cancer (PCa20)